Jean Van Rampelbergh is Doctor in Biomedical Sciences from the Université Libre de Bruxelles.
After a post-doctorate in Paris, he started a second one in 2000 in the pharma industry for Janssen Pharmaceutica Foundation, collaborating to early pre-clinical activities.
As of 2002, he shifted his activities towards the clinical part of the development. He started as a CRA for Organon and then moved to Sanofi-aventis in 2005 to successively embrace the functions of Project Leader, Clinical Operations Manager Head of the Clinical Study Unit of Sanofi in Belgium. During his last 2 years at Sanofi he was one of the five global responsible leaders for reshaping the clinical development pathway.
In 2013, he created his own consultancy company directed towards supporting spin-off and start-up companies for their clinical development needs at early stages. He recently successfully moved the biotech Imcyse into clinical stage in type 1 diabetes with excellent results in phase 1.
Next to this, Jean is eager to share his knowledge through training sessions for different audiences.